Crucible Therapeutics Limited
- Company number
- 14690230
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 27 Feb 2023
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- University Of Leeds (27 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FOLEY, Jonathan | Director | 21 Sep 2023 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Guillaume Marcel Pierre Hautbergue | Right To Appoint And Remove Directors | 27 Feb 2023 | 21 Sep 2023 |
| Argobio S.A.S. | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
14 Feb 2024 | |
| Northern Gritstone Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
14 Feb 2024 |
Connections
Owned by
Crucible Therapeutics Limited → Northern Gritstone Limited
Directors’ other companies
- FOLEY, Jonathan - Director at CFA Discovery Ltd
Companies at the same address
- Aeni Limited (17146875)
- Amplisi Limited (16625534)
- Bettison.org Limited (05604762)
- Blastech Limited (04755214)
- Cybpass Limited (16690289)
- Evolutor Limited (13882589)
- Full Scale Dynamics Limited (06680024)
- Houndkirk View Management Company Limited (16080930)
- Instruct3d Limited (15677349)
- Keapstone Therapeutics Limited (10594127)